Position Statement
What Are the Criteria by Which a Densitometric Diagnosis of Osteoporosis Can Be Made in Males and Non-Caucasians?

https://doi.org/10.1385/JCD:5:3S:S19Get rights and content

Abstract

Osteoporotic fractures are not rare in men or non-Caucasian women. However, for these groups, there is no consensus densitometric definition of osteoporosis. As is the case in Caucasian women, low bone mineral density (BMD) is associated with increased fracture risk among men and non-Caucasian women; thus, a densitometric definition of osteoporosis seems feasible. Reaching agreement on criteria for diagnosing osteoporosis in men and non-Caucasians was among the goals of the International Society for Clinical Densitometry Position Development Conference held in July 2001. To this end, the conference recommendation for males is that osteoporosis be defined as a BMD T-score of –2.5 or below the young normal mean for men. Since the relationship between BMD and fracture risk may differ between men and women, it is recommended that T-scores in men continue to be derived using a male normative database. Similarly, for non-Caucasians, the recommendation is to diagnose osteoporosis at or below a T-score of –2.5. However, given the difficulty in defining race or ethnic groups, a dearth of data, and their conflicting nature correlating BMD with fracture risk in different ethnicities, it is recommended that a uniform normative database (not adjusted for race) be utilized in the United States for T-score derivation in non-Caucasians. Note that these are current clinical recommendations, which may change as additional data accumulate. Furthermore, there was agreement that the following individuals should have their bone density measured: anyone (male or female, regardless of race) with prior fragility fractures or with conditions widely recognized to increase the risk of bone loss and fracture (such as hypogonadism, corticosteroid treatment, hyperparathyroidism, alcohol abuse, anticonvulsant use, and prior gastrectomy); women on long-term hormone replacement therapy; and in the absence of these conditions, women age 65 and older (regardless of race) and men age 70 and older.

References (41)

  • E Orwoll et al.

    Alendronate for the treatment of osteoporosis in men

    N Engl J Med

    (2000)
  • M Lunt et al.

    Bone density variation and its effects on risk of vertebral deformity in men and women studied in thirteen European centers: the EVOS study

    J Bone Miner Res

    (1997)
  • I Pande et al.

    Bone mineral density, hip axis length and risk of hip fracture in men: results from the Cornwall Hip Fracture Study

    Osteoporos Int

    (2000)
  • LJ Melton et al.

    Bone density and fracture risk in men

    J Bone Miner Res

    (1998)
  • ES Leib et al.

    International Society of Clinical Densitometry Scientific Position Development Conference, Justification and Methodology

    J Clin Densitom

    (2002)
  • E Orwoll

    Perspective: assessing bone density in men

    J Bone Miner Res

    (2000)
  • PL Selby et al.

    Do men and women fracture bones at similar bone densities?

    Osteoporos Int

    (2000)
  • JA Cauley et al.

    Do men and women fracture at the same BMD level?

    J Bone Miner Res

    (2000)
  • JA Kanis et al.

    Diagnosis of osteoporosis and fracture threshold in men

    Calcif Tissue Int

    (2001)
  • H Kroger et al.

    Bone density reduction in various measurement sites in men and women with osteoporotic fractures of spine and hip: the European Quantitation of Osteoporosis Study

    Calcif Tissue Int

    (1999)
  • Cited by (122)

    • Bone mass measurement

      2018, Encyclopedia of Endocrine Diseases
    View all citing articles on Scopus
    View full text